Currently out of the existing stock ratings of Zegbeh Jallah, 121 are a BUY (94.53%), 7 are a HOLD (5.47%).

Zegbeh Jallah

Work Performance Price Targets & Ratings Chart

Analyst Zegbeh Jallah works at CAPITAL ONE with a stock forecast success ratio of 27.31% fulfilled within 92.86 days on average. Previously, Zegbeh Jallah worked at ROTH.

Zegbeh Jallah’s has documented 248 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 27-Dec-2023.

Wall Street Analyst Zegbeh Jallah

Analyst best performing recommendations are on OCGN (OCUGEN).
The best stock recommendation documented was for OCGN (OCUGEN) at 2/3/2021. The price target of $8 was fulfilled within 5 days with a profit of $5.19 (184.7%) receiving and performance score of 369.4.

Average potential price target upside

AGTC Applied Genetic ARVN Arvinas CLSD Clearside Biomedical DARE Dare Bioscience ENTA Enanta Pharmaceuticals GLYC GlycoMimetics HARP Harpoon Therapeutics IDYA Ideaya Biosciences JNCE Jounce Therapeutics KALV Kalvista Pharmaceuticals KOD Kodiak Sciences LIFE aTyr Pharma OCGN Ocugen RZLT Rezolute TPTX Turning Point Therapeutics RAPT RAPT Therapeutics IVA Inventiva Sa XFOR X4 Pharmaceuticals IMUX Immunic SYRS Syros Pharmaceuticals AIMT Aimmune Therapeutics OTLK OUTLOOK THERAPEUTICS INC

Analyst name


Current price target

Potential Upside

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$0.01 (2.56%)

1 years 6 months 23 days ago

1/1 (100%)

$0.01 (2.56%)



1 years 6 months 24 days ago

1/10 (10%)

$13.99 (348.88%)




1 years 6 months 24 days ago

0/2 (0%)

$2.73 (29.45%)


1 years 6 months 25 days ago

0/1 (0%)

$7.55 (308.16%)



1 years 7 months 19 days ago

0/2 (0%)

$6.72 (157.01%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Zegbeh Jallah is most bullish on?

Potential upside of $0 has been obtained for OTLK (OUTLOOK THERAPEUTICS INC)

What Year was the first public recommendation made by Zegbeh Jallah?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?